You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 1 No. 2, August 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Disappearance Rates of Infused Epinephrine and Norepinephrine from Plasma

A Comparison of Normal and Schizophrenic Subjects

GERALD COHEN, Ph.D.; BERNARD HOLLAND, M.D.; MARCEL GOLDENBERG, M.D.

AMA Arch Gen Psychiatry 1959;1(2):228-231.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Recently, in the course of experiments dealing with intravenous infusions of epinephrine and norepinephrine in man,1 occasion presented itself to perform infusions on a group of normal subjects and on a group of schizophrenic patients. It appeared that data concerning plasma concentrations of epinephrine and norepinephrine during infusions had bearing on recent suggestions that schizophrenia might be related to a faulty metabolism of either of these two substances. Hoffer and co-workers,2,3 for instance, had presented evidence suggestive that certain oxidized derivatives of epinephrine, namely, adrenochrome (3-hydroxy-2,3dihydro-1-methylindole-5,6-quinone) and adrenolutin (3,5,6-trihydroxy-1-methylindole) were capable of producing transient psychoses and other mental aberrations in man when administered intravenously or orally. Thus, the view was advanced3 that a defect in epinephrine metabolism resulting in the formation of excessive quantities of adrenochrome or adrenolutin might be an etiologic factor in schizophrenia. In support of this . . . [Full Text PDF of this Article]


Author Affiliations

New York With the Technical Assistance of Joanne Sha

From the Departments of Biochemistry, Medicine, and Psychiatry of Columbia University College of Physicians and Surgeons; and from the New York State Psychiatric Institute, and the Presbyterian Hospital.

Present address (Dr. Holland): Department of Psychiatry, Emory University School of Medicine, Atlanta, Ga.


Footnotes

Submitted for publication Sept. 29, 1958.

Presented before the Intersociety Session of the 42d Annual Meeting of the Federation of American Societies for Experimental Biology, Philadelphia, April 14-18, 1958.

Supported by Research Grant H-1045 (C-6) of the U. S. Public Health Service, National Institutes of Health; and by the Florence L. Pond Gift to the Presbyterian Hospital.

Dr. Goldenberg died on July 30, 1958.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.